Cargando…
Predictors of persistent disease following initial thyroid cancer management
OBJECTIVES: To study which factors increase the risk of persistent disease in differentiated and poorly differentiated thyroid carcinoma. METHODS: A retrospective chart review of all consecutive differentiated and poorly differentiated thyroid cancer patients from King Abdulaziz University Hospital,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502972/ https://www.ncbi.nlm.nih.gov/pubmed/32789420 http://dx.doi.org/10.15537/smj.2020.8.25227 |
_version_ | 1783584300903432192 |
---|---|
author | Samargandy, Shaza A. Merdad, Mazin A. |
author_facet | Samargandy, Shaza A. Merdad, Mazin A. |
author_sort | Samargandy, Shaza A. |
collection | PubMed |
description | OBJECTIVES: To study which factors increase the risk of persistent disease in differentiated and poorly differentiated thyroid carcinoma. METHODS: A retrospective chart review of all consecutive differentiated and poorly differentiated thyroid cancer patients from King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia, a tertiary care center, between 2004 and 2018. Logistic regression analysis was performed to predict factors associated with less than excellent response to treatment. RESULTS: We included 186 patients with complete data records; 81.1% were females. Papillary thyroid carcinoma comprised 88.1% of the neoplasms. In total, 55.9% of patients attained an excellent response to treatment by the end of the first year following treatment. All patients with distant metastasis had persistent disease. On univariate analysis, female gender was associated with excellent response (p=0.002). Lymph node metastasis, extrathyroidal extension, vascular invasion, and cancer multifocality were all found to be inversely related to excellent response (p<0.05 for all). On multivariate analysis only lymph node metastasis was associated with a decreased adjusted odds of an excellent response (p=0.007). CONCLUSION: Patients with lymph node metastasis are at high risk for persistent disease following initial thyroid cancer management. Careful monitoring of these patients is warranted. |
format | Online Article Text |
id | pubmed-7502972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Saudi Medical Journal |
record_format | MEDLINE/PubMed |
spelling | pubmed-75029722021-03-11 Predictors of persistent disease following initial thyroid cancer management Samargandy, Shaza A. Merdad, Mazin A. Saudi Med J Original Article OBJECTIVES: To study which factors increase the risk of persistent disease in differentiated and poorly differentiated thyroid carcinoma. METHODS: A retrospective chart review of all consecutive differentiated and poorly differentiated thyroid cancer patients from King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia, a tertiary care center, between 2004 and 2018. Logistic regression analysis was performed to predict factors associated with less than excellent response to treatment. RESULTS: We included 186 patients with complete data records; 81.1% were females. Papillary thyroid carcinoma comprised 88.1% of the neoplasms. In total, 55.9% of patients attained an excellent response to treatment by the end of the first year following treatment. All patients with distant metastasis had persistent disease. On univariate analysis, female gender was associated with excellent response (p=0.002). Lymph node metastasis, extrathyroidal extension, vascular invasion, and cancer multifocality were all found to be inversely related to excellent response (p<0.05 for all). On multivariate analysis only lymph node metastasis was associated with a decreased adjusted odds of an excellent response (p=0.007). CONCLUSION: Patients with lymph node metastasis are at high risk for persistent disease following initial thyroid cancer management. Careful monitoring of these patients is warranted. Saudi Medical Journal 2020-08 /pmc/articles/PMC7502972/ /pubmed/32789420 http://dx.doi.org/10.15537/smj.2020.8.25227 Text en Copyright: © Saudi Medical Journal https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Samargandy, Shaza A. Merdad, Mazin A. Predictors of persistent disease following initial thyroid cancer management |
title | Predictors of persistent disease following initial thyroid cancer management |
title_full | Predictors of persistent disease following initial thyroid cancer management |
title_fullStr | Predictors of persistent disease following initial thyroid cancer management |
title_full_unstemmed | Predictors of persistent disease following initial thyroid cancer management |
title_short | Predictors of persistent disease following initial thyroid cancer management |
title_sort | predictors of persistent disease following initial thyroid cancer management |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502972/ https://www.ncbi.nlm.nih.gov/pubmed/32789420 http://dx.doi.org/10.15537/smj.2020.8.25227 |
work_keys_str_mv | AT samargandyshazaa predictorsofpersistentdiseasefollowinginitialthyroidcancermanagement AT merdadmazina predictorsofpersistentdiseasefollowinginitialthyroidcancermanagement |